Results 201 to 210 of about 60,534 (304)

Symptomatic Dermatographism Misattributed to Cockroach Exposure: A Diagnostic Pitfall. [PDF]

Cureus
Kogan S, Bhardwaj S, Ghimire S, Tewari A, Tewari R.   +4 more
europepmc   +1 more source

The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database

Pediatric Dermatology, EarlyView.
ABSTRACT Background Dermatologic conditions are a significant reason for pediatric hospitalizations in the United States. A prior analysis of the 2012 Kids' Inpatient Database (KID) established a national benchmark for this burden, but changes in medical coding, healthcare delivery, and demographics necessitate an updated assessment.
Shiv Patel, Aayush Shah, Vibhusha Kolli, Peter A. Lio   +3 more
wiley   +1 more source

Allergic Contact Dermatitis to Terminalia Chebula Fruit Extract in Antiaging Creams. [PDF]

Contact Dermatitis
Blanchard M, Marchal O, Blanchard G, Piletta-Zanin P.   +3 more
europepmc   +1 more source

Enteral Green Beans in the Management of Neonatal Irritant Diaper Dermatitis

Pediatric Dermatology, EarlyView.
ABSTRACT Irritant diaper dermatitis (IDD) is frequently observed in neonatal intensive care units and is often exacerbated by chronic loose stools. Despite standard treatments, erosive or persistent IDD remains challenging to manage. We introduced pureed green beans into enteral feeds as a source of fiber to improve stool consistency and reduce skin ...
Allison Chiou, Lindsay Tufte, Matthew Mahoney, Christina Boull   +3 more
wiley   +1 more source

Correction: Kubik et al. An Infrared Energy Device for the Treatment of Facial Skin Aging. Biomedicines 2025, 13, 2878. [PDF]

Biomedicines
Kubik P, Gruszczyński W, Pawłowska A, Malinowski M, Baran B, Pawłowska-Kubik A, Kodłubański Ł, Łukasik B.   +7 more
europepmc   +1 more source

Long‐Term Safety and Efficacy of Once‐Daily and Proactive Twice‐Weekly Roflumilast Cream 0.05% for Mild‐to‐Moderate Atopic Dermatitis in Children Aged 2–5 Years From a 52‐Week, Phase 3 Trial (INTEGUMENT‐OLE)

Pediatric Dermatology, EarlyView.
ABSTRACT Background INTEGUMENT‐PED/NCT04845620, a 4‐week, phase 3 trial, demonstrated efficacy and safety of roflumilast cream 0.05% in children aged 2–5 years with mild‐to‐moderate atopic dermatitis (AD). A phase 3 open‐label extension trial (INTEGUMENT‐OLE [NCT04804605]) investigated long‐term outcomes continuing roflumilast cream for ≤ 56 weeks ...
Lawrence F. Eichenfield, Mercedes E. Gonzalez, Mark Boguniewicz, Tracy Funk, Adelaide A. Hebert, Vimal H. Prajapati, Chesahna Kindred, Rocco Serrao, Lisa Swanson, David Krupa, Scott Snyder, Melissa S. Seal, Diane Hanna, Patrick Burnett, David R. Berk   +14 more
wiley   +1 more source

Autoeczematization: A Rare Complication of Contact Dermatitis Triggered by Topical Antibiotic Ointment. [PDF]

Cureus
Miura G, Yoshimoto N, Kurosawa S, Nakamura H.   +3 more
europepmc   +1 more source

Novel Combination of UVA‐1 Phototherapy With Topical Tofacitinib for Treating Eosinophilic Fasciitis With Morphea: Case Report

Pediatric Dermatology, EarlyView.
ABSTRACT Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic ...
Daphne M. Cheung, Ye‐Jean Park, Nadia Luca, Frankie Fraulin, Marie‐Anne Brundler, Michele Ramien   +5 more
wiley   +1 more source